Assertio Holdings (ASRT) Change in Acquisitions & Divestments (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Change in Acquisitions & Divestments came in at $30.4 million in Q1 2026, up 6.62% year-on-year from $28.5 million in Q1 2025, and up 0.72% quarter-over-quarter from $30.2 million in Q4 2025.
Assertio Holdings (ASRT) Change in Acquisitions & Divestments (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Change in Acquisitions & Divestments across 5 years of filings, most recently posting $30.4 million for Q1 2026.
- Change in Acquisitions & Divestments for Q1 2026 came in at $30.4 million, up 6.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $117.3 million (up 50.01% YoY), and the FY2025 annual result was $115.4 million, up 132.19% from the prior year.
- Change in Acquisitions & Divestments came in at $30.4 million for Q1 2026 at Assertio Holdings, up from $30.2 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $30.4 million in Q1 2026 to a low of -$2.2 million in Q4 2023.
- The 4-year median for Change in Acquisitions & Divestments is $28.1 million (2025), against an average of $24.2 million.
- Across the five-year window, Change in Acquisitions & Divestments soared 1292.34% in 2024 and increased 6.62% in 2026, its largest moves.
- Assertio Holdings' Change in Acquisitions & Divestments stood at -$2.2 million in 2023, then jumped by 1292.34% to $26.2 million in 2024, then climbed by 15.26% to $30.2 million in 2025, then climbed by 0.72% to $30.4 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $30.4 million (Q1 2026), $30.2 million (Q4 2025), and $27.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.37 Mn |
| Mar 31, 2026 | 30.37 Mn |
| Dec 31, 2025 | 30.15 Mn |
| Dec 31, 2025 | 30.15 Mn |
| Sep 30, 2025 | 27.66 Mn |
| Sep 30, 2025 | 27.66 Mn |
| Jun 30, 2025 | 29.09 Mn |
| Jun 30, 2025 | 29.09 Mn |
| Mar 31, 2025 | 28.48 Mn |
| Mar 31, 2025 | 28.48 Mn |
| Dec 31, 2024 | 26.16 Mn |
| Dec 31, 2024 | 26.16 Mn |
| Sep 30, 2024 | 23.53 Mn |
| Sep 30, 2024 | 23.53 Mn |
| Dec 31, 2023 | -2.19 Mn |
| Dec 31, 2023 | -2.19 Mn |
| Sep 30, 2019 | 3.46 Mn |
| Sep 30, 2019 | 3.46 Mn |